The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
1 other identifier
interventional
32
1 country
1
Brief Summary
This study aims to determine the effectiveness of the use of acupuncture in relieving sensory and motor symptoms as well as functional impairment and quality of life of patients with chemotherapy induced peripheral neuropathy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 16, 2014
CompletedFirst Posted
Study publicly available on registry
December 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedNovember 13, 2015
November 1, 2015
1.2 years
September 16, 2014
November 11, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
neurological symptoms
This study aims to determine the effectiveness of the use of acupuncture in relieving sensory and motor symptoms of patients with chemotherapy induced peripheral neuropathy
up to 7 weeks
Secondary Outcomes (2)
functional impairment
up to 7 weeks
quality of life
up to 7 weeks
Study Arms (2)
Acupuncture
ACTIVE COMPARATORacupuncture
orientation group
SHAM COMPARATORmedical management guidelines for foot / hands care, sensory desensitization, risk prevention guidelines, proper ergonomics and orthoses when necessary.
Interventions
medical management guidelines for foot / hands care, sensory desensitization, risk prevention guidelines, proper ergonomics and orthoses when necessary.
Eligibility Criteria
You may qualify if:
- Cancer adult patients with CIPN -
You may not qualify if:
- Other neuropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto do Cancer do Estado de São Paulo ICESP
São Paulo, São Paulo, 01246 000, Brazil
Related Publications (1)
D'Alessandro EG, Nebuloni Nagy DR, de Brito CMM, Almeida EPM, Battistella LR, Cecatto RB. Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study. BMJ Support Palliat Care. 2022 Mar;12(1):64-72. doi: 10.1136/bmjspcare-2018-001542. Epub 2019 Jun 29.
PMID: 31256014DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rebeca B Cecatto, PhD
Instituto do Cancer do Estado de São Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Rebeca Boltes Cecatto
Study Record Dates
First Submitted
September 16, 2014
First Posted
December 5, 2014
Study Start
September 1, 2014
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
November 13, 2015
Record last verified: 2015-11